false 2025 --09-30 Q3 0001497649 0001497649 2024-10-01 2025-06-30 0001497649 2025-11-10 0001497649 2025-06-30 0001497649 2024-09-30 0001497649 2025-04-01 2025-06-30 0001497649 2024-04-01 2024-06-30 0001497649 2023-10-01 2024-06-30 0001497649 us-gaap:CommonStockMember 2024-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001497649 GSTX:StockReceivableMember 2024-09-30 0001497649 GSTX:StockPayableMember 2024-09-30 0001497649 us-gaap:NoncontrollingInterestMember 2024-09-30 0001497649 us-gaap:RetainedEarningsMember 2024-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001497649 us-gaap:CommonStockMember 2024-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001497649 GSTX:StockReceivableMember 2024-12-31 0001497649 GSTX:StockPayableMember 2024-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2024-12-31 0001497649 us-gaap:RetainedEarningsMember 2024-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001497649 2024-12-31 0001497649 us-gaap:CommonStockMember 2025-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001497649 GSTX:StockReceivableMember 2025-03-31 0001497649 GSTX:StockPayableMember 2025-03-31 0001497649 us-gaap:NoncontrollingInterestMember 2025-03-31 0001497649 us-gaap:RetainedEarningsMember 2025-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001497649 2025-03-31 0001497649 us-gaap:CommonStockMember 2023-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001497649 GSTX:StockReceivableMember 2023-09-30 0001497649 GSTX:StockPayableMember 2023-09-30 0001497649 us-gaap:RetainedEarningsMember 2023-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001497649 2023-09-30 0001497649 us-gaap:CommonStockMember 2023-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001497649 GSTX:StockReceivableMember 2023-12-31 0001497649 GSTX:StockPayableMember 2023-12-31 0001497649 us-gaap:RetainedEarningsMember 2023-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001497649 2023-12-31 0001497649 us-gaap:CommonStockMember 2024-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001497649 GSTX:StockReceivableMember 2024-03-31 0001497649 GSTX:StockPayableMember 2024-03-31 0001497649 us-gaap:RetainedEarningsMember 2024-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001497649 2024-03-31 0001497649 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001497649 GSTX:StockReceivableMember 2024-10-01 2024-12-31 0001497649 GSTX:StockPayableMember 2024-10-01 2024-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2024-10-01 2024-12-31 0001497649 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0001497649 2024-10-01 2024-12-31 0001497649 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001497649 GSTX:StockReceivableMember 2025-01-01 2025-03-31 0001497649 GSTX:StockPayableMember 2025-01-01 2025-03-31 0001497649 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001497649 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001497649 2025-01-01 2025-03-31 0001497649 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001497649 GSTX:StockReceivableMember 2025-04-01 2025-06-30 0001497649 GSTX:StockPayableMember 2025-04-01 2025-06-30 0001497649 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001497649 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001497649 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001497649 GSTX:StockReceivableMember 2023-10-01 2023-12-31 0001497649 GSTX:StockPayableMember 2023-10-01 2023-12-31 0001497649 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001497649 2023-10-01 2023-12-31 0001497649 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001497649 GSTX:StockReceivableMember 2024-01-01 2024-03-31 0001497649 GSTX:StockPayableMember 2024-01-01 2024-03-31 0001497649 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001497649 2024-01-01 2024-03-31 0001497649 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001497649 GSTX:StockReceivableMember 2024-04-01 2024-06-30 0001497649 GSTX:StockPayableMember 2024-04-01 2024-06-30 0001497649 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001497649 us-gaap:CommonStockMember 2025-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001497649 GSTX:StockReceivableMember 2025-06-30 0001497649 GSTX:StockPayableMember 2025-06-30 0001497649 us-gaap:NoncontrollingInterestMember 2025-06-30 0001497649 us-gaap:RetainedEarningsMember 2025-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001497649 us-gaap:CommonStockMember 2024-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001497649 GSTX:StockReceivableMember 2024-06-30 0001497649 GSTX:StockPayableMember 2024-06-30 0001497649 us-gaap:RetainedEarningsMember 2024-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001497649 2024-06-30 0001497649 us-gaap:CommonStockMember 2024-10-01 2025-06-30 0001497649 us-gaap:EquipmentMember 2025-06-30 0001497649 us-gaap:EquipmentMember 2024-09-30 0001497649 us-gaap:ComputerEquipmentMember 2025-06-30 0001497649 us-gaap:ComputerEquipmentMember 2024-09-30 0001497649 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001497649 us-gaap:FurnitureAndFixturesMember 2024-09-30 0001497649 2023-10-01 2024-09-30 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2012-06-28 2012-06-29 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2012-06-29 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2014-06-16 2014-06-17 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2014-06-17 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2016-01-30 2016-02-01 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2016-02-01 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2024-10-01 2025-06-30 0001497649 us-gaap:SecuredDebtMember GSTX:ConvertibleNotesPayable1Member 2023-10-01 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-11-19 2024-11-21 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-11-21 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-10-01 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2023-10-01 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-01-20 2025-01-21 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-01-21 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2024-10-01 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2023-10-01 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-02-25 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2024-10-01 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2023-10-01 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-02-20 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2024-09-30 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2024-10-01 2025-06-30 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2023-10-01 2024-09-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2023-12-31 0001497649 GSTX:FirstQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2023-10-01 2023-12-31 0001497649 GSTX:FirstQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:SecondQuarterMember 2024-03-31 0001497649 GSTX:SecondQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-01-01 2024-03-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarterMember 2024-06-30 0001497649 GSTX:ThirdQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-04-01 2024-06-30 0001497649 GSTX:SecondQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-04-01 2024-06-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarter2025Member 2024-12-31 0001497649 GSTX:FirstQuarter2025Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarter2025Member 2025-06-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarter2025Member 2025-06-30 0001497649 GSTX:ThirdQuarter2025Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2025-04-01 2025-06-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2015-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2025-06-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2024-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2019-01-15 0001497649 GSTX:GVBGmbHMember GSTX:AusquartzSandsMember 2023-09-11 0001497649 GSTX:GVBGmbHMember GSTX:AusquartzSandsMember 2023-09-10 2023-09-11 0001497649 2023-02-27 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-02-27 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-07-01 2023-07-31 0001497649 GSTX:AndrewLiangMember 2022-12-04 2022-12-05 0001497649 GSTX:AndrewLiangMember 2022-12-05 0001497649 GSTX:MILabsPtyLtdMember GSTX:JasonMayMember GSTX:ManagementServicesMember 2024-10-01 2025-06-30 0001497649 GSTX:MILabsPtyLtdMember GSTX:JasonMayMember GSTX:ManagementServicesMember 2025-04-01 2025-06-30 0001497649 GSTX:SativusInvestmentsMember GSTX:PaulSaffronMember GSTX:CorporateAdvisorServicesMember 2024-10-01 2025-06-30 0001497649 GSTX:SativusInvestmentsMember GSTX:PaulSaffronMember GSTX:CorporateAdvisorServicesMember 2025-04-01 2025-06-30 0001497649 GSTX:ParallelFourtyLLCMember GSTX:MsKristiSteeleAndMrDavidMember GSTX:ManagementServicesMember 2024-10-01 2025-06-30 0001497649 GSTX:ParallelFourtyLLCMember GSTX:MsKristiSteeleAndMrDavidMember GSTX:ManagementServicesMember 2025-04-01 2025-06-30 0001497649 GSTX:AusquartzMember GSTX:RussellKrauseMember GSTX:ManagementServicesMember 2024-10-01 2025-06-30 0001497649 GSTX:AusquartzMember GSTX:RussellKrauseMember GSTX:ManagementServicesMember 2025-04-01 2025-06-30 0001497649 GSTX:HamineralsPtyLtdMember GSTX:MrAndrewHamiltonMember GSTX:ManagementServicesMember 2024-10-01 2025-06-30 0001497649 GSTX:HamineralsPtyLtdMember GSTX:MrAndrewHamiltonMember GSTX:ManagementServicesMember 2025-04-01 2025-06-30 0001497649 GSTX:STRVentureMember 2025-06-30 0001497649 GSTX:BoardOfDirectorsMember 2024-10-01 2025-06-30 0001497649 GSTX:BoardOfDirectorsMember 2023-10-01 2024-09-30 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:PaulSaffronMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:PaulSaffronMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:KristiSteeleMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:KristiSteeleMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:DavidHareMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:DavidHareMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:AndrewHamiltonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:AndrewHamiltonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:NeilMorrisMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:NeilMorrisMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:AnthonyLeighMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:AnthonyLeighMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:RussellKrauseMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:RussellKrauseMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2024-11-16 2024-11-20 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-11-16 2024-11-20 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2024-11-18 2024-11-21 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-11-18 2024-11-21 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2024-12-01 2024-12-02 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-12-01 2024-12-02 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2024-12-01 2024-12-02 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-12-01 2024-12-02 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-01-20 2025-01-21 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-01-20 2025-01-21 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-02-25 2025-02-26 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-02-25 2025-02-26 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-02-25 2025-02-26 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-02-25 2025-02-26 0001497649 GSTX:MrDavidHalsteadMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:MrDavidHalsteadMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 GSTX:MrYanZhouMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:MrYanZhouMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-06-30 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-04-09 2025-04-10 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-06-01 2025-06-11 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-06-01 2025-06-13 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-06-01 2025-06-26 0001497649 us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2024-10-01 2025-06-30 0001497649 GSTX:WMCMember 2025-06-30 0001497649 GSTX:WMCMember 2025-04-01 2025-06-30 0001497649 GSTX:WMCMember 2024-10-01 2025-06-30 0001497649 2023-11-01 0001497649 GSTX:JansonMayMember GSTX:DirectorsAnnualCompensationMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrDavidHalsteadMember GSTX:DirectorsAnnualCompensationMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrJeffreyFreedmanMember GSTX:DirectorsAnnualCompensationMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrAndrewLiangMember GSTX:DirectorsAnnualCompensationMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrCharlesWantrupMember GSTX:DirectorsAnnualCompensationMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:BrooksideCommunicationsMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 0001497649 GSTX:IlgarIsayevMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 0001497649 GSTX:OmnicomOCCMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 0001497649 GSTX:RochaAndAssociatesMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 0001497649 GSTX:MrRussellKrauseMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 0001497649 GSTX:NoteholderMember GSTX:ConvertibleLoanAgreementMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:ArranBooteMember GSTX:DebtToEquityAgreementMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:AnthonyLeighMember GSTX:PerformanceBonusMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:STRVentureMember GSTX:PerformanceBonusMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrIlgarIsayevMember GSTX:PerformanceBonusMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrRussellKrauseMember GSTX:DebtToEquityAgreementMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:MrJasonMayMember GSTX:DebtToEquityAgreementMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:DebtToEquityAgreementMember srt:ScenarioForecastMember 2025-07-01 2025-09-30 0001497649 GSTX:StuartAllenMember srt:ScenarioForecastMember GSTX:ConsultingAgreementMember 2025-07-01 2025-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

false 2026 --09-30 Q1 0001497649 0001497649 2025-10-01 2025-12-31 0001497649 2026-04-08 0001497649 2025-12-31 0001497649 2025-09-30 0001497649 2024-10-01 2024-12-31 0001497649 us-gaap:CommonStockMember 2025-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001497649 GSTX:StockReceivableMember 2025-09-30 0001497649 GSTX:StockPayableMember 2025-09-30 0001497649 us-gaap:NoncontrollingInterestMember 2025-09-30 0001497649 us-gaap:RetainedEarningsMember 2025-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001497649 us-gaap:CommonStockMember 2024-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001497649 GSTX:StockReceivableMember 2024-09-30 0001497649 GSTX:StockPayableMember 2024-09-30 0001497649 us-gaap:NoncontrollingInterestMember 2024-09-30 0001497649 us-gaap:RetainedEarningsMember 2024-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001497649 2024-09-30 0001497649 us-gaap:CommonStockMember 2025-10-01 2025-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2025-12-31 0001497649 GSTX:StockReceivableMember 2025-10-01 2025-12-31 0001497649 GSTX:StockPayableMember 2025-10-01 2025-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2025-10-01 2025-12-31 0001497649 us-gaap:RetainedEarningsMember 2025-10-01 2025-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2025-12-31 0001497649 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001497649 GSTX:StockReceivableMember 2024-10-01 2024-12-31 0001497649 GSTX:StockPayableMember 2024-10-01 2024-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2024-10-01 2024-12-31 0001497649 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0001497649 us-gaap:CommonStockMember 2025-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001497649 GSTX:StockReceivableMember 2025-12-31 0001497649 GSTX:StockPayableMember 2025-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2025-12-31 0001497649 us-gaap:RetainedEarningsMember 2025-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001497649 us-gaap:CommonStockMember 2024-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001497649 GSTX:StockReceivableMember 2024-12-31 0001497649 GSTX:StockPayableMember 2024-12-31 0001497649 us-gaap:NoncontrollingInterestMember 2024-12-31 0001497649 us-gaap:RetainedEarningsMember 2024-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001497649 2024-12-31 0001497649 us-gaap:EquipmentMember 2025-12-31 0001497649 us-gaap:EquipmentMember 2025-09-30 0001497649 us-gaap:ComputerEquipmentMember 2025-12-31 0001497649 us-gaap:ComputerEquipmentMember 2025-09-30 0001497649 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001497649 us-gaap:FurnitureAndFixturesMember 2025-09-30 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2012-06-28 2012-06-29 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2012-06-29 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2014-06-16 2014-06-17 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2014-06-17 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2016-01-30 2016-02-01 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2016-02-01 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable1Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 us-gaap:SecuredDebtMember GSTX:ConvertibleNotesPayable1Member 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-11-19 2024-11-21 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-11-21 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable2Member us-gaap:SecuredDebtMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-01-20 2025-01-21 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-01-21 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable3Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2024-10-01 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-02-25 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable4Member us-gaap:SecuredDebtMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-02-25 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-02-26 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable5Member us-gaap:SecuredDebtMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2025-10-21 2025-10-22 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2025-10-22 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2025-09-30 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayable6Member us-gaap:SecuredDebtMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2023-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2023-10-01 2023-12-31 0001497649 GSTX:FirstQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:FirstQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:SecondQuarterMember 2024-03-31 0001497649 GSTX:SecondQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-01-01 2024-03-31 0001497649 GSTX:SecondQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarterMember 2024-06-30 0001497649 GSTX:ThirdQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:SecondQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:ThirdQuarterMember GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarter2025Member 2024-12-31 0001497649 GSTX:FirstQuarter2025Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2024-10-01 2024-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarter2025Member 2025-12-31 0001497649 GSTX:ThirdQuarter2025Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2025-10-01 2025-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FourthQuarter2025Member 2025-09-30 0001497649 GSTX:FourthQuarter2025Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2025-07-01 2025-09-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarter2026Member 2025-12-31 0001497649 GSTX:FirstQuarter2026Member GSTX:ConvertibleNotesPayableRelatedPartyMember 2025-10-01 2025-12-31 0001497649 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2025-12-31 0001497649 us-gaap:NotesPayableOtherPayablesMember 2025-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2019-01-15 0001497649 GSTX:GVBGmbHMember GSTX:AusquartzSandsMember 2023-09-11 0001497649 GSTX:GVBGmbHMember GSTX:AusquartzSandsMember 2023-09-10 2023-09-11 0001497649 2023-02-27 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-02-27 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-07-01 2023-07-31 0001497649 GSTX:AndrewLiangMember 2022-12-04 2022-12-05 0001497649 GSTX:AndrewLiangMember 2022-12-05 0001497649 GSTX:MILabsPtyLtdMember GSTX:JasonMayMember GSTX:ManagementServicesMember 2025-10-01 2025-12-31 0001497649 GSTX:SativusInvestmentsMember GSTX:PaulSaffronMember GSTX:ManagementServicesMember 2025-10-01 2025-12-31 0001497649 GSTX:ParallelFourtyLLCMember GSTX:MsKristiSteeleAndMrDavidMember GSTX:ManagementServicesMember 2025-10-01 2025-12-31 0001497649 GSTX:AusquartzMember GSTX:RussellKrauseMember GSTX:ManagementServicesMember 2025-10-01 2025-12-31 0001497649 GSTX:HamineralsPtyLtdMember GSTX:MrAndrewHamiltonMember GSTX:ManagementServicesMember 2025-10-01 2025-12-31 0001497649 GSTX:STRVentureMember 2025-12-31 0001497649 GSTX:BoardOfDirectorsMember 2025-10-01 2025-12-31 0001497649 GSTX:BoardOfDirectorsMember 2024-10-01 2024-12-31 0001497649 GSTX:JansonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:PaulSaffronMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:RussellKrauseMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:KristiSteeleMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:DavidHareMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:AndrewHamiltonMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:MsKristineWooMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:MrAnthonyLeighMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:MrIlgarIsayevMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:MrStephenBarnettMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:ConvertibleLoanAgreementMember 2025-10-20 2025-10-22 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:DebtConvertibleAgreementMember 2025-11-01 2025-11-19 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:LoanExtensionAndAmendmentAgreementMember 2025-12-01 2025-12-02 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:LoanExtensionAndAmendmentAgreementMember 2025-10-20 2025-10-22 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:LoanExtensionAndAmendmentAgreementMember 2025-12-01 2025-12-02 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:LoanExtensionAndAmendmentAgreementMember 2025-10-20 2025-10-22 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:DebtConvertibleAgreementMember 2025-12-01 2025-12-03 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:DebtConvertibleAgreementMember 2025-12-01 2025-12-03 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:DebtConvertibleAgreementMember 2025-12-01 2025-12-09 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:SharePurchaseAgreementMember 2025-12-01 2025-12-29 0001497649 us-gaap:InvestorMember us-gaap:CommonStockMember GSTX:SharePurchaseAgreement1Member 2025-12-01 2025-12-29 0001497649 GSTX:Investor1Member us-gaap:CommonStockMember GSTX:SharePurchaseAgreement1Member 2025-12-01 2025-12-29 0001497649 GSTX:TheQuartzSiliconMaterialsCompanyPtyLtdMember us-gaap:CommonStockMember GSTX:CounsultingAgreementMember 2025-10-01 2025-12-31 0001497649 GSTX:WMCMember 2025-12-31 0001497649 GSTX:WMCMember 2025-10-01 2025-12-31 0001497649 GSTX:QSMAUMember 2025-12-31 0001497649 GSTX:TheQuartzSiliconMaterialsCompanyPtyLtdMember 2025-10-01 2025-12-31 0001497649 2023-11-01 0001497649 2024-10-01 2025-09-30 0001497649 GSTX:MrPaulSaffronMember GSTX:ConsultingAgreementMember 2026-01-01 2026-01-02 0001497649 GSTX:MrDannyKennedyMember GSTX:ConsultingAgreementMember 2026-01-01 2026-01-02 0001497649 GSTX:MrVictorPereiraMember GSTX:ConsultingAgreementMember 2026-01-01 2026-01-02 0001497649 GSTX:MrArnoldSockMember GSTX:ConsultingAgreementMember us-gaap:SubsequentEventMember 2026-02-01 0001497649 GSTX:DebtConversionAgreementMember 2026-03-28 2026-03-31 0001497649 GSTX:DebtConversionAgreement1Member 2026-03-28 2026-03-31 0001497649 GSTX:DebtConversionAgreement2Member 2026-03-28 2026-03-31 0001497649 GSTX:PurchaseAgreementMember 2026-03-28 2026-03-31 0001497649 GSTX:ThompsonFamilyTrustMember GSTX:PerformanceBonusMember 2026-03-28 2026-03-31 0001497649 GSTX:MatthewBrownMember GSTX:PerformanceBonusMember 2026-03-28 2026-03-31 0001497649 GSTX:MarkAndersonMember GSTX:PerformanceBonusMember 2026-03-28 2026-03-31 0001497649 us-gaap:SubsequentEventMember 2026-01-01 2026-01-14 0001497649 us-gaap:SubsequentEventMember 2026-02-24 2026-02-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION~~

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the ~~quarterly~~ quarterly period ended ~~June~~December 3031, 2025

☐ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission File Number: 333-174194

GRAPHENE & SOLAR TECHNOLOGIES ~~LTD~~LIMITED (Exact name of registrant as specified in its charter)

colorado		27-2888719
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

11201 North Tatum Blvd., Suite 300

Phoenix, AZ 85028

(Address of principal executive offices, including Zip Code)

(602) 388-8335

(Issuer’s telephone number, including area code)

(Former name or former address if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically , every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant ~~was~~ was required to submit and post such files). Yes ☐☒ No ☒☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated ~~Filer~~filer ☐ Accelerated ~~Filer~~filer ☐ Non-accelerated ~~Filer~~filer ☐ Smaller reporting company ☒☐ Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act . ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~November~~April 108, ~~2025~~ 2026, the registrant had ~~718~~676,194,059 ~~outstanding~~ outstanding shares of common stock.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

FORM 10-Q

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION		Page
PART I	FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Balance Sheets (Unaudited)	31
Item 2.	Condensed Consolidated Statements of Operations and other comprehensive income (Unaudited)	42
Item 3.	Condensed Consolidated ~~Statements~~Statement of ~~Changes in~~ Stockholders’ Deficiency (Unaudited) Three Months Ended December 31, 2025 and 2024	53
Item 4.	Condensed Consolidated Statements of Cash Flows (Unaudited)	85
Item 5.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	1918
Item 6.	Controls and Procedures.	21
PART II — OTHER INFORMATION
PART II OTHER INFORMATION
Item 1	Legal Proceedings	22
Item 1A	Risk Factors	22
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3	Defaults on Senior Securities	22
Item 4	Mine Safety Disclosures	22
Item 5	Other Information	22
Item 6.	Exhibits.	22
~~SIGNATURES~~	SIGNATURES	23

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2025 (Unaudited)			September 30, 2025
	December 31, 2025 (Unaudited)			September 30, 2025
Assets
Current Assets:
Cash	$	4278,~~791~~842		$	157,~~845~~365
Prepaid expenses		11,~~266~~512			11,~~923~~355
Total Current Assets		5490,~~057~~354			1368,~~768~~720
Other Assets:
Furniture and equipment, net of depreciation $83,461 and $88,064		23,929			26,262
Furniture and equipment, net of depreciation $91,642 and $89,418		18,741			19,465
Other Receivable		32,~~498~~172			891,~~864~~645
Other Assets		~~191~~116,~~071~~405			16116,~~204~~192
Right of Use Asset		~~117~~96,~~994~~126			~~160~~107,~~615~~024
Total Assets	$	~~390~~323,~~549~~798		$	~~306~~313,~~713~~046
Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable and other payable	$	1,~~603~~897,~~671~~000		$	1,~~295~~866,~~394~~742
Accrued interest payable		~~260~~271,~~062~~258			~~222~~248,~~679~~881
Due to related party		21,~~209~~531,~~249~~763			~~852~~1,~~743~~836,248
Lease Liability		4954,~~618~~521			4659,~~968~~834
Notes payable – $60,000 in default, at 06/30/25 and 09/30/24		310,328			324,928
Notes payable – $60,000 in default, at 12/31/25 and 09/30/25		315,794			312,316
Notes payable – related party		9495,~~610~~200			9794,~~395~~804
Convertible notes payable, net of discount $142,209 and $1,129		178,644			101,876
Convertible notes payable, net of discount $94,012 and $117,185		258,701			184,828
Convertible notes payable – related party, net of discount $69,298 and $4,083		153,379			84,426
Convertible notes payable – related party, net of discount $46,427 and $58,452		276,250			214,225
Total Current Liabilities		4,~~859~~700,~~561~~487			34,~~026~~817,~~409~~878
Lease Liability		7246,~~710~~056			~~117~~51,~~277~~861
Total Liabilities	$	4,~~932~~746,~~271~~543		$	34,~~143~~869,~~686~~739
Stockholders’ Deficit
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding		—			—
Common stock: 800,000,000 shares authorized; $0.00001 par value; 702,944,059 and 569,779,887 shares issued and outstanding		7,031			5,698
Common stock: 1,500,000,000 shares authorized; $0.00001 par value; 726,194,059 and 726,194,059 shares issued and outstanding		7,262			7,262
Additional paid-in capital		69,~~567~~971,~~502~~613			6869,~~769~~708,~~472~~061
Stock Receivable		(795,000	)		(795,000	)
Stock Payable		131,~~100~~509,631			—606,635
Accumulated deficit		(7375,~~581~~179,~~011~~116	)		(7174,~~015~~320,~~630~~226	)
Accumulated other comprehensive income		~~247~~68,~~269~~599			~~198~~239,~~672~~991
Non-Controlling Interest		(~~613~~5,734	)		(~~185~~3,416	)
Total Stockholders’ Deficit		(4,~~541~~422,~~722~~745	)		(24,~~836~~556,~~973~~693	)
Total Liabilities and Stockholders’ Deficit	$	~~390~~323,~~549~~798		$	~~306~~313,~~713~~046

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ending June 30,						Nine Months Ending June 30,
	Three Months Ending December 31,
	2025			2024			~~2025~~			~~2024~~
Revenue	$	—		$	—		$	—		$	—
Operating Expenses:
Professional Services		785,329			275,151			2,279,549			972,805
Professional fees		714,731			945,655
General and administrative		18,545			29,674			101,380			68,598
General and administration		45,140			20,109
Total operating expenses		~~803~~759,~~874~~871			~~304~~965,~~825~~764			~~2,380,929~~			~~1,041,403~~
Loss from operations		(~~803~~759,~~874~~871	)		(~~304~~965,~~825~~764	)		~~(2,380,929~~	)		~~(1,041,403~~	)
Other Income (Expense):
Other income (expense)		(5	)		4,792			(56,119	)		18,632
Other income/(expense)		—			(57,256	)
Interest expense		(7359,~~837~~092	)		(1319,~~098~~597	)		~~(128,761~~	)		~~(35,822~~	)
Loss on extinguishment of debt		—(43,734	)		~~(1,700~~—	)		—			~~(1,700~~	)
Total Other Income (Expense)		(73102,~~842~~826	)		(1076,~~006~~853	)		~~(184,880~~	)		~~(18,890~~	)
Net Income (Loss) from continuing operations	$	(~~877~~862,~~716~~697	)	$	(~~314~~1,~~831~~042,617	)	$	~~(2,565,809~~	)	$	~~(1,060,293~~	)
Net Loss from discontinued operations		—			~~103,308~~—			—			~~103,308~~
Net Income (Loss)	$	(~~877~~862,~~716~~697	)	$	(~~418~~1,~~139~~042,617	)	$	~~(2,565,809~~	)	$	~~(1,163,601~~	)
Net Loss attributed to non-controlling interest	$	293,807		$	—105		$	~~428~~		$	—
Net Loss attributed to Graphene & Solar Technologies Ltd.	$	(~~877~~858,~~687~~890	)	$	(~~418~~1,~~139~~042,512	)	$	~~(2,565,381~~	)	$	~~(1,163,601~~	)
Other Comprehensive Income	$	~~(40~~171,~~851~~392	)	$	~~(38~~102,~~243~~104	)	$	~~48,597~~		$	~~(59,386~~	)
Net Comprehensive Loss	$	(~~918~~687,~~538~~498	)	$	(~~456~~940,~~382~~408	)	$	~~(2,516,784~~	)	$	~~(1,222,987~~	)
Net Loss available to common shareholders	$	(~~918~~687,~~538~~498	)	$	(~~456~~940,~~382~~408	)	$	~~(2,516,784~~	)	$	~~(1,222,987~~	)
Income (Loss) per share:
Basic and diluted loss per common share	$	(0.00	)	$	(0.00	)
Basic and diluted	$	(0.00	)	$	(0.00	)		(0.00	)	$	(0.00	)
Weighted average number of common shares outstanding		840,626,034			611,906,548
Weighted average shares outstanding		684,016,586			427,075,459			649,041,287			424,277,899

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Unaudited)

Three ~~and Nine~~ Months Ended December ~~June 30~~31, 2025 and 2024

	Common Stock				Additional		Stock				Stock	~~Non-Controlling~~			Non-Controlling	~~Accumulated~~			Accumulated	~~Accumulated Comprehensive~~			Accumulated Comprehensive	~~Stockholders’~~			Stockholders’
	Shares		Amount		Paid-in		Receivable				Payable	~~Interest~~			Interest	~~Deficit~~			Deficit	~~Income~~			Income	~~Deficit~~			Deficit
Balance September 30, 2024		569,779,887		5,698		68,769,472		(795,000	)	–			(185	)			(71,015,630	)			198,672				(2,836,973	)
Balance September 30, 2025		726,194,059		7,262		69,708,061		(795,000	)			606,635				(3,416	)			(74,320,226	)			239,991				(4,556,693	)
Stock-based compensation		53,453,544		535		321,311		—					—				—				—				321,846
Shares issued for cash		—		—		—		—				172,900				—				—				—				172,900
Debt Discount on Notes Payable		20,000,000		200		179,800		—		–			—				—				—				180,000
Stock-based compensation		—		—		—		—				48,015				—				—				—				48,015
Foreign currency translation adjustment		—		—		—		—					—				—				102,104				102,104
Debt Discount on Notes Payable		—		—		—		—				1,000				—				—				—				1,000
Other comprehensive income, net of tax		—		—		—		—					(105	)			(1,042,512	)			—				(1,042,617	)
Shares issued for Debt Extinguishment		—		—		—		—				177,934				—				—				—				177,934
Balance December 31, 2024		643,233,431		6,433		69,270,583		(795,000	)	–			(290	)			(72,058,142	)			300,776				(3,275,640	)
Settlement of Related Party Debt		—		—		251,853		—				503,147				—				—				—				755,000
Debt Discount on Notes Payable		12,010,628		121		102,896		—		–			—				—				—				103,017
Sale of Subsidiary Shares		—		—		11,699		—				—				1,519				—				—				13,218
Foreign currency translation adjustment		—		—		—		—				—	—			(30	—)			—	~~(12,656~~	)		(171,392	~~(12,656~~)	)		(171,422	)
Other comprehensive income, net of tax		—		—		—		—				—	~~(294~~	)		(3,807	~~(645,182~~)	)		(858,890	—)			—	~~(645,476~~	)		(862,697	)
Balance March 31, 2025		655,244,059		6,554		69,373,479		(795,000	)	–			(584	)			(72,703,324	)			288,120				(3,830,755	)
Balance December 31, 2025		726,194,059		7,262		69,971,613		(795,000	)			1,509,631				(5,734	)			(75,179,116	)			68,599				(4,422,745	)

	Common Stock				Additional		Stock			Stock		Non-Controlling			Accumulated			Accumulated Comprehensive		Stockholders’
	Shares		Amount		Paid-in		Receivable			Payable		Interest			Deficit			Income		Deficit
Balance September 30, 2024		569,779,887		5,698		68,769,472		(795,000	)		—		(185	)		(71,015,630	)		198,672		(2,836,973	)
Stock-based compensation		53,453,544		535		321,311		—			—		—			—			—		321,846
Debt Discount on Notes Payable		20,000,000		200		94,536		—			—		—			—			—		94,736
Foreign currency translation adjustment		—		—		—		—			—		—			—			102,104		102,104
Other comprehensive income, net of tax		—				—		—			—		(105	)		(1,042,512	)		—		(1,042,617	)
Balance December 31, 2024		643,233,431		6,433		69,185,319		(795,000	)		—		(290	)		(72,058,142	)		300,776		(3,360,904	)

The accompanying notes are an integral part of these consolidated financial statements.

	Common Stock				Additional		Stock			Stock		Non-Controlling			Accumulated			Accumulated Comprehensive			Stockholders’
	Shares		Amount		Paid-in		Receivable			Payable		Interest			Deficit			Income			Deficit
Balance March 31, 2025		655,244,059		6,554		69,373,479		(795,000	)		—		(584	)		(72,703,324	)		288,120			(3,830,755	)
Shares issued for cash		1,000,000		10		9,990		—			13,100		—			—			—			23,100
Stock-based compensation		22,000,000		220		65,780		—			—		—			—			—			66,000
Debt Settlement		22,200,000		222		110,778		—			—		—			—			—			111,000
Debt Discount on Notes Payable		2,500,000		25		7,475		—			—		—			—			—			7,500
Foreign currency translation adjustment		—		—		—		—			—		—			—			(40,851	)		(40,851	)
Other comprehensive income, net of tax		—				—		—			—		(29	)		(877,687	)		—			(877,716	)
Balance June 30, 2025		702,944,059		7,031		69,567,502		(795,000	)		13,100		(613	)		(73,581,011	)		247,269			(4,541,722	)

The accompanying notes are an integral part of these consolidated financial statements.

																Accumulated			Total
	Common Stock				Additional		Stock			Stock			Accumulated’			Comprehensive			Stockholders’
	Shares		Amount		Paid-in		Receivable			Payable			Deficit			Income			Deficit
Balance September 30, 2023		421,292,610		4,213		63,883,859		(795,000	)		—			(68,375,078	)		302,977			(4,979,029	)
Stock Based Compensation		—		—		—		—			44,400			—			—			44,400
Debt Discount on Notes Payable		600,000		6		11,577		—			7,096			—			—			18,679
Foreign currency translation adjustment		—		—		—		—			—			—			(109,130	)		(109,130	)
Net loss		—		—		—		—			—			(369,136	)		—			(369,136	)
Balance December 31, 2023		421,892,610		4,219		63,895,436		(795,000	)		51,496			(68,744,214	)		193,847			(5,394,216	)
Shares issued for cash		500,000		5		4,995		—			—			—			—			5,000
Stock Based Compensation		2,000,000		20		51,980		—			—			—			—			52,000
Debt Discount on Notes Payable		250,000		3		923		—			—			—			—			926
Debt Extinguishment		500,000		5		1,695		—			—			—			—			1,700
Foreign currency translation adjustment		—		—		—		—			—			—			87,987			87,987
Net loss		—		—		—		—			—			(376,326	)		—			(376,326	)
Balance March 31, 2024		425,142,610		4,252		63,955,029		(795,000	)		51,496			(69,120,540	)		281,834			(5,622,929	)
Shares issued for cash		200,000		2		1,998		—			—			—			—			2,000
Stock Based Compensation		10,500,000		105		109,669		—			(44,400	)		—			—			65,374
Debt Settlement		14,677,307		147		2,003,040		—			—			—			—			2,003,187
Debt Discount on Notes Payable		750,000		7		8,205		—			(7,096	)		—			—			1,116
Sale of Subsidiary		—		—		1,646,819		—			—			—			—			1,646,819
Foreign currency translation adjustment		—		—		—		—			—			—			(38,243	)		(38,243	)
Net loss		—		—		—		—			—			(418,139	)		—			(418,139	)
Balance June 30, 2024		451,269,917		4,513		67,724,760		(795,000	)		—			(69,538,679	)		243,591			(2,360,815	)

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the Nine-Month Period Ended June 30, 2025 and 2024


	Three-Month Period Ended
	December 31, (Unaudited)
	2025			2024
Cash flows from operating activities
Net Income (loss)	$	(862,697	)	$	(1,042,617	)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation		48,015			321,846
Depreciation expense		973			84
Loss on Debt Extinguishment		45,534			—
Amortization of discount		36,898			8,287
Changes in operating assets and liabilities:
Accounts payable		152,202			20,705
Accrued interest payable		22,297			11,310
Other assets		—			(150,000	)
Other receivables		(509	)		77,093
Right of use assets		12,134			10,961
Lease liabilities		(12,413	)		(10,661	)
Due to related parties		450,488			653,437
Net cash used in operating activities		(107,078	)		(99,555	)

Cash flows from investing activities
Sale of Subsidiary Shares		13,218			—
Cash acquired from purchase of subsidiary		—			—
Net cash from investing activities		13,218			—

Cash flows from financing activities
Proceeds from issuance of common stock		172,900			—
Due to Affiliates		—			(584	)
Issuance of convertible note		50,000			100,000
Issuance of convertible note – related party		50,000			100,000
Net cash from financing activities		272,900			199,416

Effect of currency translations to cash flow		(157,563	)		1,313
Net change in cash and cash equivalents		21,477			101,174
Beginning of Period		57,365			1,845
End of Period	$	78,842		$	103,019

Supplemental cash flow information
		2025			2024
Interest paid	$	—		$	—
Taxes	$	—		$	—
Non-cash investing and financing activities:
Settlement of Debt for Common Stock	$	132,400		$	—
Settlement of Related Party Debt		755,000			—
Issuance of Common Stock as Debt Discount		1,000			94,736
Capitalization of Interest		—			9,168

(Unaudited)

	2025			2024
Cash flows from operating activities
Net Income (loss)	$	(2,565,809	)	$	(1,163,601	)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation		387,846			161,774
Depreciation expense		246			252
Loss on Debt Extinguishment		—			1,700
Amortization of discount		81,231			12,161
Changes in operating assets and liabilities:
Accounts payable		349,776			295,850
Accrued interest payable		46,797			23,661
Other assets		(175,760	)		—
Other receivables		79,681			4,015
Right of use assets		33,028			—
Lease liabilities		(32,146	)		—
Due to related parties		1,467,621			611,027
Net cash used in operating activities		(327,489	)		(53,161	)
Cash flows from investing activities		—			—
Cash flows from financing activities
Proceeds from issuance of common stock		23,100			7,000
Due to Affiliates		(1,034	)		—
Issuance of convertible note		220,106			—
Issuance of convertible note – related party		125,000			70,399
Net cash from financing activities		367,172			77,399
Effect of currency translations to cash flow		1,263			(24,189	)
Net change in cash and cash equivalents		40,946			(11	)
Beginning of period		1,845			1,094
End of period	$	42,791		$	1,083

Supplemental cash flow information	Quarter ended June 30,
	2025		2024
Interest paid	$	—	$	—
Taxes	$	—	$	—
Noncash investing and financing activities:
Settlement of Debt for Common Stock	$	111,000	$	2,003,187
Issuance of Common Stock as Debt Discount		290,517		20,721
Capitalization of Interest		9,168		—

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – BASIS OF PRESENTATION

These consolidated financial statements of Graphene & Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar’s ~~Technologies~~ audited financial statements as of September 30, ~~2024~~2025.

Going ~~Concern~~ Concern – The Company has incurred cumulative net losses since inception of $7375,~~581~~179,~~011~~116, atas ~~June~~of 30December 31, 2025. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through ~~the~~ future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Principles of Consolidation and Basis of Presentation –— The consolidated financial statements include the accounts of Graphene & ~~Solar~~ Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, ~~2024~~2025.

Use of Estimates - – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial ~~statements~~ statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities.

Cash and Cash Equivalents –- Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the Company had $4278,~~791~~842 and $157,~~845~~365 in cash, respectively, and no no cash equivalents.

Stock-Based Compensation –- ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

During the quarter ~~three months~~ ended ~~June~~December 3031, 2025, the Company issued ~~47,700,000~~0 shares of the Company’s common stock to members of the Board of Directors, employees, and consultants.

During the quarter ~~nine months~~ ended ~~June~~December 3031, ~~2025~~2024, the Company issued ~~an aggregate of 135~~51,~~664~~500,~~172~~000 shares of the Company’s common stock to members of the Board of Directors, employees, and consultants.

Total stock-based compensation expense was $48,015 and $321,311 for the quarters ended December 31, 2025 and 2024, respectively.

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

Other comprehensive income loss was $40171,~~851~~392 and $38102,43104 for the three months ended ~~June~~December 3031, 2025 and 2024, respectively.

~~Other~~Accumulated other comprehensive income was $4868,~~597~~599 ~~for~~and ~~the~~$239,991, ~~nine~~as ~~months~~of ~~ended June~~December 3031, 2025, and anSeptember ~~other comprehensive loss of $59~~30,~~386~~ ~~for the nine months ended June 30~~2025, ~~2024~~respectively.

~~Accumulated~~Earnings ~~other~~Per Share ~~comprehensive~~- ~~income~~Basic ~~was~~earnings ~~$247,269~~per ~~and~~share ~~$198,672, as~~have been calculated based upon the weighted-average number of ~~June~~common ~~30,~~shares ~~2025~~outstanding. ~~and~~Diluted earnings ~~September~~per ~~30,~~share ~~2024,~~were ~~respectively~~not calculated as such potential shares would be anti-dilutive.

~~Earnings~~Reclassifications ~~Per~~- ~~Share~~Certain –amounts ~~Basic~~previously ~~earnings~~presented ~~per~~for ~~share~~prior periods have been ~~calculated~~reclassified ~~based~~to ~~upon~~conform to the ~~weighted-average~~current ~~number~~presentation. ofThe ~~common shares outstanding.~~reclassifications ~~Diluted~~had ~~earnings~~no ~~per~~effect ~~share~~on ~~were~~net ~~not~~loss, ~~calculated~~working ascapital ~~such~~or ~~potential~~equity ~~shares~~previously ~~would be anti-dilutive~~reported.

~~Reclassifications~~Recent –Accounting Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.Pronouncements

Management does not believe that any recently issued but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

Recently Adopted Accounting Standards

Effective for the fiscal year ended September 30, 2025, the Company adopted the provisions of ASC 2023-07, “Segment Reporting” (Topic 280): Improvements to Reportable Segment Disclosures. See Segment Reporting.

Segment Reporting

Effective as of the fiscal year ended September 30, 2025, the Company adopted the provisions of ASC 2023-07, “Segment Reporting” (Topic 280): Improvements to Reportable Segment Disclosures. Operating segments are components of an enterprise about which separate financial information is available and are evaluated regularly by management, namely the Chief Operating Decision Maker (“CODM”), in order to assess performance and allocate resources. The Company has identified its Chief Executive Officer as the CODM.

The CODM evaluates the Company’s financial results and allocates resources on a consolidated basis. Based on this evaluation, the Company has determined that it operates as a single operating and reportable segment.

Although the Company has identified geographic regions for purposes of internal review and future revenue analysis, the Company and its subsidiaries have not generated any revenues to date. Accordingly, no geographic revenue information has been presented for the quarter ended December 31, 2025.

The Company’s assets are located in multiple jurisdictions and are managed on a consolidated basis. Because the Company operates as a single operating unit and has not generated revenues to date, management believes that presenting additional geographic asset information would not be meaningful. The Company will reassess its segment and geographic reporting disclosures as operations expand and revenues are generated.

In accordance with ASC 280, the Company provides the following segment information:

Schedule of segment information
	Three-Month Period Ended December 31, 2025
Revenue	$	—

Total Operating Expenses		759,871

Loss From Operations		(759,871	)

Total Other Income (Expense)		(102,826	)

Net Income (Loss)		(862,697	)

Net Loss Attributed to Non-Controlling Interest		3,807

Other Comprehensive Income		171,392

Net Comprehensive Loss	$	(687,498	)

NOTE 3 – PROPERTY AND EQUIPMENT

Property and equipment as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025 are summarized as follows:

Schedule of property and equipment
	June 30,			September 30,
	December 31,			September 30,
	2025			~~2024~~2025
Laboratory and factory equipment	$	7972,~~104~~843		$	7672,~~609~~041
Computers		—4,074			43,~~094~~999
Furniture and fixtures		2833,~~286~~465			3332,~~623~~843
Property and equipment, gross		107,390			114,326
		110,383			108,883
Less accumulated depreciation		(8391,~~461~~642	)		(8889,~~064~~418	)
Net property and equipment	$	2318,~~929~~741		$	2619,~~262~~465

Depreciation ~~expense~~ expense for the quarter ended ~~June~~December 3031, 2025 and the year-end September 30, ~~2024~~2025 were $~~164~~973 and $~~338~~4,352, respectively.

108

NOTE 4 – OTHER ASSETS

Other assets consist of the following:

Schedule of other assets
	June 30,		September 30,
	December 31,		September 30,
	2025		~~2024~~2025
Security deposit – rental bond (Melbourne, Australia)	$	15,~~311~~645	$	1615,~~204~~432
Deferred offering costs		~~175~~100,760		—100,760
Total other assets	$	~~191~~116,~~071~~405	$	16116,~~204~~192

The security deposit represents a rental bond paid in connection with the Company’s commercial lease agreement in Melbourne, Australia. The deposit is refundable at the conclusion of the lease, subject to the terms of the lease agreement.

Deferred offering costs consist of legal, accounting, and other professional fees incurred in connection with anticipated capital raising transactions. As of ~~June~~December 3031, 2025, no offering had been completed. These costs have been capitalized in accordance with ASC 340-10 and will be ~~offset~~ offset against the proceeds of such offerings, if and when they occur.

NOTE 5 – NOTES PAYABLE

The Company’s indebtedness as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025 were as follows:

Schedule of notes payable
Description	~~June~~December 3031, 2025		September 30, ~~2024~~2025
Convertible notes payable, net of discount $142,209 and $1,129	$	178,644	$	101,876
Notes payable – $60,000 in default, at 12/31/25 and 09/30/25	$	315,794	$	312,316
Convertible notes payable – related party, net of discount $69,298 and $4,083		153,379		84,426
Notes payable – related party		95,200		94,804
Notes Payable – $60,000 in default, at 06/30/25 and 09/30/24	$	310,328	$	324,928
Convertible notes, net of discount $94,012 and $119,014	$	258,701	$	184,829
Notes Payable – Related Parties	$	94,610	$	97,395
Convertible notes payable – related party, net of discount $46,427 and $58,452	$	276,250		214,225

Convertible Notes Payable

On June 29, 2012, the Company issued convertible secured notes payable totaling $8,254,500 to a group of private investors. The notes matured on ~~June~~ June 30, 2015. The notes, with interest at 15%, were convertible at the discretion of the holders, into common shares of the Company at the rate of $3.31 per share. Unable to make the required interest payment on March 31, 2014, the notes became due on demand. Effective June 17, 2014, with the noteholder approval, the assets securing the convertible notes were sold with the net proceeds of approximately $5,200,000 being distributed to the noteholders. Noteholders were to receive payment for the remaining balance due on the notes in the form of an exchange for the common stock of the Company at the rate of $3.31 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation payable was $~~198~~184,~~088~~ 611 and $~~190~~182,~~151~~622, including accrued interest of $~~127~~132,~~341~~004 and $~~119~~130,~~403~~015, respectively. As of ~~June 30~~December 31, 2025 and September 30, ~~2024~~2025, the exchange obligation was for 5955,~~845~~774 shares and 5755,~~447~~173 shares of common stock, respectively.

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per share. The Company has not extended the maturity date and the note is in default. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total ~~convertible~~ convertible note payable balance was $5859,~~249~~762 and $5659,005, including accrued interest of $2829,~~249~~762 and $2629,005 respectively. As of ~~June 30~~December 31, 2025 and September 30, ~~2024~~2025, the exchange obligation was for ~~116~~119,~~498~~524 shares and ~~112~~118,010 shares of common stock, respectively.

On ~~November~~ November 21, 2024, the Company issued a convertible secured note payable of $100,000 to an individual. The note matures on November 21, 2026, and includes interest at 10%. The note is convertible at discretion of the holder into common shares of the Company at the rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total convertible note payable balance is $~~105~~110,~~808~~849 and $0108,329 including accrued interest of $510,~~808~~849 and $08,329 respectively. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation is for ~~423~~443,~~232 shares~~396 shares and 0433,316 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 10,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $90,000 upon the issuance of the notes, with subsequent ~~amortization~~ amortization of debt discount totaling $2749,~~247~~932.

119

On ~~January~~ January 21, 2025, the Company issued a convertible secured note payable of $100,000 to an individual. The note matures on January 21, 2027, and includes interest at 10%. The note is convertible at discretion of the holder into common shares of the Company at the rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total convertible note payable balance is $~~104~~110,~~959~~000 and $0107,479, including accrued interest of $410,~~959~~000 and $07,479, respectively. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation is for ~~419~~ 440,~~836~~000 shares and 0429,916 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 10,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $100,000 upon the issuance of the notes, with subsequent amortization of debt discount totaling $2147,~~918~~123.

On ~~February~~ February 26, 2025, the Company issued a convertible secured note payable of $16,665 to an individual. The note matures on February 26, 2027, and includes interest at 10%. The note is convertible at discretion of the holder into common shares of the Company at the rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total convertible note payable balance is $1718,~~350~~190 and $017,770, including accrued interest of $~~685~~1,525 and $01,105, respectively. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation is for 6972,~~400 shares~~760 shares and 071,080 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 1,666,500 shares of common stock to the lender. The Company recorded an initial debt discount of $2,500 upon the issuance of the notes, with subsequent ~~amortization~~ amortization of debt discount totaling $~~425~~1,055.

On ~~February~~ February 26, 2025, the Company issued a convertible secured note payable of $3,441 to an individual. The note matures on February 26, 2027, and includes interest at 10%. The note is convertible at discretion of the holder into common shares of the Company at the rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total convertible note payable balance is $3,~~583~~756 and $03,669, including accrued interest of $~~141~~315 and $0228, respectively. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation is for 1415,~~332 shares~~024 shares and 014,676 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 344,128 shares of common stock to the lender. The Company recorded an initial debt discount of $516 upon the issuance of the notes, with subsequent ~~amortization~~ amortization of debt discount totaling $88218.

On October 22, 2025, the Company issued a convertible secured note payable of $50,000 to an individual. The note matures on October 22, 2027, and includes interest at 10%. The note is convertible at discretion of the holder into common shares of the Company at the rate of $0.25 per share. As of December 31, 2025 and September 30, 2025, the total convertible note payable balance is $51,260 and $0, including accrued interest of $1,260 and $0, respectively. As of December 31, 2025 and September 30, 2025, the exchange obligation is for 205,040 shares and 0 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 5,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $500 upon the issuance of the notes, with subsequent amortization of debt discount totaling $48.

Convertible Notes Payable – Related Party

During the quarter ended December 31, 2023, the Company entered into an agreement to issue convertible notes payable with an accredited investor. Notably, there exists a professional relationship between the Company and the investor, facilitated by a mutual director serving on the boards of both entities. These notes carry an aggregate principal balance of $50,000 and accrue interest at a rate of 10% per annum. The notes matured in October 2024 and December 2024. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total balance of promissory notes payable stood at $5861,~~198~~293 and $5459,~~459~~899, inclusive of accrued interest totaling $85,~~198~~999 and $4,~~459~~605, respectively. Moreover, as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation associated with these notes amounted to ~~581~~612,~~980~~930 and ~~544~~ 598,~~590~~990 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 1,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $18,679 upon the issuance of the notes, with subsequent ~~amortization~~ amortization of debt discount totaling $18,679. During the quarter ended December 31, 2024, the Company amended the note to extend the maturity date from October 2024 and December 2024 to December 2025. Additionally, the noteholder agreed to capitalize $5,294 of accrued interest into the principal balance of the note. As consideration for the extension, the Company issued 1,105,884 shares of common stock to the lender, valued at approximately $111, which was recorded as an expense during the period. All other terms of the note remain unchanged. In December 2025, the Company further amended the note to extend the maturity date to May 2026. As consideration for the extension, the Company issued 608,233 shares of common stock to the lender, valued at $8,698, which was recorded as an expense during the period. No other terms of the note were changed.

During the quarter ended March 31, 2024, the Company entered into an agreement to issue a convertible note payable with a director serving on the board. The note carries an aggregate principal balance of $27,828 and accrues interest at a rate of 10% per annum. The note matured in March 2025. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2025 and September 30, 2024, the total balance of promissory notes payable stood at $32,777 and $30,696, inclusive of accrued interest totaling $4,949 and $2,868, respectively. Moreover, as of June 30, 2025 and September 30, 2024, the exchange obligation associated with these notes amounted to 327,770 and 306,960 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 750,000 shares of common stock to the lender. The Company recorded an initial debt discount of $2,493 upon the issuance of the notes, with subsequent amortization of debt discount totaling $2,493. During the quarter ended December 31, 2024, the Company amended the note to extend the maturity date from March 2025 to December 2025. Additionally, the noteholder agreed to capitalize $3,333 of accrued interest into the principal balance of the note. As consideration for the extension, the Company issued 623,220 shares of common stock to the lender, valued at approximately $62, which was recorded as an expense during the period. All other terms of the note remain unchanged.

12During the quarter ended March 31, 2024, the Company entered into an agreement to issue a convertible note payable with a director serving on the board. The note carries an aggregate principal balance of $27,828 and accrues interest at a rate of 10% per annum. The note matured in March 2025. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of December 31, 2025 and September 30, 2025, the total balance of promissory notes payable stood at $34,542 and $33,756, inclusive of accrued interest totaling $3,381 and $2,595. Moreover, as of December 31, 2025 and September 30, 2025, the exchange obligation associated with these notes amounted to 345,420 and 337,560 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 750,000 shares of common stock to the lender. The Company recorded an initial debt discount of $2,493 upon the issuance of the notes, with subsequent amortization of debt discount totaling $2,493. During the quarter ended December 31, 2024, the Company amended the note to extend the maturity date from March 2025 to December 2025. Additionally, the noteholder agreed to capitalize $3,333 of accrued interest into the principal balance of the note. As consideration for the extension, the Company issued 623,220 shares of common stock to the lender, valued at approximately $62, which was recorded as an expense during the period. All other terms of the note remain unchanged. In December 2025, the Company further amended the note to extend the maturity date to May 2026. As consideration for the extension, the Company issued 342,771 shares of common stock to the lender, valued at $4,902, which was recorded as an expense during the period. No other terms of the note were changed.

During the quarter ended June 30, 2024, the Company entered into an agreement to issue a convertible note payable with a director serving on the board. The note carries an aggregate principal balance of $10,681 and accrues interest at a rate of 10% per annum. The note ~~matures~~matured in ~~June~~ June 2025. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total balance of promissory notes payable stood at $1112,~~919~~439 and $1112,~~121~~157, inclusive of accrued interest totaling $1,~~238~~217 and $~~440~~935, respectively. Moreover, as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation associated with these notes amounted to ~~119~~124,~~190~~390 and ~~111~~121,~~210~~ 570 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 350,000 shares of common stock to the lender. The Company recorded an initial debt discount of $14,~~116~~ 204 upon the issuance of the notes, with subsequent amortization of debt discount totaling $1,116. ~~During~~ During the quarter ended December 31, 2024, the Company amended the note to extend the maturity date from June 2025 to December 2025. Additionally, the noteholder agreed to capitalize $541 of accrued interest into the principal balance of the note. As consideration for the extension, the Company issued 224,440 shares of common stock to the lender, valued at approximately $22, which was recorded as an expense during the period. All other terms of the note remain unchanged. In December 2025, the Company further amended the note to extend the maturity date to May 2026. As consideration for the extension, the Company issued 123,442 shares of common stock to the lender, valued at $1,765, which was recorded as an expense during the period. No other terms of the note were changed.

During the quarter ended December 31, 2024, the Company entered into an agreement to issue a convertible note payable with two officers of the Company. The note carries an aggregate principal balance of $100,000 and accrues interest at a rate of 10% per annum. The note matures in November 2026. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total balance of promissory notes payable stood at $~~105~~110,~~808~~849 and $0108,329, inclusive of accrued interest totaling $510,~~808~~849 and $08,329, respectively. Moreover, as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the exchange obligation associated with these notes amounted to ~~423~~443,~~232~~396 and 0433,316 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 10,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $90,000 upon the issuance of the notes, with subsequent amortization of debt discount totaling $2750,~~370~~055.

During the quarter ended June 30, 2025, the Company entered into an agreement to issue a convertible note payable with two officers of the Company. The note carries an aggregate principal balance of $25,000 and accrues interest at a rate of 10% per annum. The note matures in April 2027. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.25 per share. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total balance of promissory notes payable stood at $2526,~~623~~884 and $026,253, inclusive of accrued interest totaling $~~623~~1,884 and $01,253, respectively. Moreover, the exchange obligation associated with these notes amounted to ~~102~~ 107,~~492~~536 and 0 105,012 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 2,500,000 shares of common stock to the lender. The Company recorded an initial debt discount of $7,500 upon the issuance of the notes, with subsequent amortization of debt discount totaling $~~832~~2,723.

During the quarter ended September 30, 2025, the Company entered into an agreement to issue a convertible note payable with two officers of the Company. The note carries an aggregate principal balance of $50,000 and accrues interest at a rate of 10% per annum. The note matures in August 2027. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.25 per share. As of December 31, 2025 and September 30, 2025, the total balance of promissory notes payable stood at $52,096 and $50,836, inclusive of accrued interest totaling $2,096 and $836, respectively. Moreover, the exchange obligation associated with these notes amounted to 208,384 and 203,344 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 5,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $1,500 upon the issuance of the notes, with subsequent amortization of debt discount totaling $292.

During the quarter ended December 31, 2025, the Company entered into an agreement to issue a convertible note payable with two officers of the Company. The note carries an aggregate principal balance of $50,000 and accrues interest at a rate of 10% per annum. The note matures in October 2027. Additionally, the note offers the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.25 per share. As of December 31, 2025 and September 30, 2025, the total balance of promissory notes payable stood at $51,260 and $0, inclusive of accrued interest totaling $1,260 and $0, respectively. Moreover, the exchange obligation associated with these notes amounted to 205,040 and 0 shares of common stock, respectively. In return for providing the loan, the Company authorized and issued 5,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $500 upon the issuance of the notes, with subsequent amortization of debt discount totaling $48.

Notes Payable and Other Loans

During ~~2015~~ 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The ~~notes~~ notes were due on demand and included interest at 10%. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total promissory notes payable ~~balance~~ balance was $~~119~~122,~~214~~238 and $~~114~~120,726, including accrued interest of $5962,~~214~~238 and $5460,726, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

On September 11, 2023, Ausquartz Sands Pty Ltd entered into a Loan Agreement with GVB GmbH for $~~160~~250,~~925~~000, with a fixed annual interest rate of 2.15% and a maturity date of August 31, 2025. This liability was assumed by the Company following its acquisition of Ausquartz Group Holdings Pty Ltd on July 28, 2024. As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the total notes payable balance was $~~170~~262,~~203~~ 561 and $~~167~~261,~~570~~207, including interest of $612,~~453~~561 and $311,~~820~~207, respectively.

Related Party Loans

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $46,043 was received by the company as of ~~June~~December 3031, 2025) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum.

During July 2023, MI Labs Pty Ltd loaned Ausquartz Sands Pty Ltd US$31,352. The loan is a demand note on zero interest. This liability was assumed by the Company following its acquisition of Ausquartz Group Holdings Pty Ltd on July 28, 2024.

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum.

1312

NOTE 6 – RELATED PARTY

MI Labs Pty Ltd, a management company controlled by Mr. Jason May, the Company’s Chief Executive Officer and a Company Director, provides ~~management~~ management services to the Company for which the Company is charged $25,000 monthly. During the three months ended ~~June~~December 3031, 2025, the ~~Company~~ Company incurred charges to operations of $75,000 with respect to this arrangement.

Sativus Investments, a management company controlled by Mr. Paul Saffron, the Company’s Chief Operations Officer, provides management services to the Company for which the Company is charged $20,000 monthly. During the three months ended ~~June~~December 3031, 2025, the Company incurred charges to operations of $60,000 with respect to this arrangement.

Parallel40 LLC, a management company controlled by Ms. Kristi Steele and Mr. David Hare, the Company’s Chief Sustainability Officers, provides management services to the Company for which the Company was charged $30,000 monthly. During the three months ended ~~June~~December 3031, 2025, ~~the~~ the Company incurred charges to operations of $90,000 with respect to this arrangement.

Russell Krause, the Chief Executive Officer for Ausquartz Group Holdings Pty Ltd, provides management services to the Company for which the Company ~~was~~ was charged $25,000 monthly. During the three months ended ~~June~~December 3031, 2025, the Company incurred charges to operations of $75,000 with respect to this arrangement.

Haminerals Pty Ltd, a management company controlled by Mr. Andrew Hamilton, the Company’s Chief Operations Officer (Australia), provides management services to the Company for which the Company was charged $20,000 monthly. During the three months ended ~~June~~December 3031, 2025, the Company ~~incurred~~ incurred charges to operations of $60,000 with respect to this arrangement.

Parallel40 LLC, a management company controlled by Ms. Kristi Steele, a Company Officer, and Mr. David Hare, a Company Officer, entered into a convertible note agreement with the Company – see NOTE 35.

Pagemark Limited, a management company controlled by Mr. David Halstead, a Company Director, entered into a convertible note agreement with the Company – see NOTE 35.

Allegro Investments Limited entered into a convertible note agreement with the Company. The Company and Allegro Investments Limited share a professional relationship wherein a director serves on the boards of both entities – see NOTE 35.

STR ~~Ventures~~ Ventures is considered a related party of the Company due to its ownership of more than 5% of the Company’s outstanding stock. As of the quarter ~~period~~ ended ~~June~~December 3031, 2025, the Company owed STR Ventures $~~290~~393,300 in accrued consulting fees. These fees relate to ongoing ~~consulting~~ consulting services provided by STR Ventures under the terms of an existing consulting agreement.

During ~~nine-months~~ ~~period~~the quarters ended ~~June~~December 3031, 2025 and 2024, stock-based compensation expense relating to directors, officers, affiliates and related parties was $~~387~~32,650 (7343,~~500~~250,000 shares) and $~~184~~314,~~685~~ 550 (1450,~~005,~~500,000 shares), respectively.

NOTE 7 – STOCKHOLDERS’ EQUITY

~~133,164,172 new~~There ~~common~~were no common shares ~~were~~ issued during the ~~nine-month~~quarter ~~period~~ended ~~ending~~December ~~June 30~~31, 2025. The Company has a total of 5,778,367 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at ~~June~~December 3031, ~~2024~~2025.

Pursuant to to the terms of a consulting agreement, the Company ~~issued~~granted 5,000,000 shares of common stock to Mr. Jason May as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$35,500~~as onstock ~~the~~payable ~~grant date, based~~within on the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0071 per share.~~

Pursuant to the terms of a consulting agreement, the Company issued 2,000,000 shares of common stock to Mr. Paul Saffron as compensation for services rendered during the fiscal year ending September 30, 2025. The shares were valued at a fair value of $14,200 on the grant date, based on the closing market price of $0.0071 per share.13

Pursuant to to the terms of a consulting agreement, the Company ~~issued~~granted 12,000,000 shares of common stock to MsMr. ~~Kristi~~Paul ~~Steele~~Saffron as compensation for ~~services~~ services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$7,100~~as onstock ~~the~~payable ~~grant date,~~within ~~based on~~ the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0071 per share.~~

Pursuant to to the terms of a consulting agreement, the Company ~~issued~~granted 12,~~000~~500,000 shares of common stock to Mr. ~~David~~Russell ~~Hare~~Krause as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$7,100~~as onstock ~~the~~payable ~~grant date, based~~within on the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0071 per share.~~

Pursuant to the terms of a consulting agreement, the Company ~~issued~~granted 21,000,000 shares of common stock to MrMs. ~~Andrew~~Kristi ~~Hamilton~~Steele as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$14,200~~as onstock ~~the~~payable ~~grant~~within ~~date, based on~~ the ~~closing~~shareholders’ equity, ~~market~~pending ~~price of $0~~issuance.~~0071 per share.~~

Pursuant to the terms of a consulting agreement, the Company ~~issued~~granted 101,000,000 shares of common stock to Mr. ~~Neil~~David ~~Morris~~Hare as compensation for services ~~rendered~~ rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$71,000~~as onstock ~~the~~payable ~~grant~~within ~~date,~~the ~~based~~shareholders’ onequity, ~~the~~pending ~~closing market price of $0~~issuance.~~0071 per share.~~

Pursuant to to the terms of a consulting agreement, the Company ~~issued~~granted ~~a total of~~ 2,000,000 shares of common stock to ~~STR~~Mr. ~~Ventures~~Andrew Hamilton as compensation ~~for~~ for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$14,200~~as onstock ~~the grant~~payable ~~date,~~within ~~based on~~ the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0071 per share.~~

Pursuant to to the terms of a consulting agreement, the Company ~~issued~~granted a total of 20,000,000 shares of common stock to ~~STR~~Ms. ~~Ventures~~Kristine Woo as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$110,000~~as onstock ~~the grant~~payable ~~date,~~within ~~based on~~ the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0055 per share.~~

Pursuant to the terms of a consulting agreement, the Company ~~issued~~granted 1,000,000 shares of common stock to Mr. Anthony Leigh as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$7,100~~as onstock ~~the~~payable ~~grant~~within ~~date, based on~~ the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0071 per share.~~

Pursuant to the terms of a consulting agreement, the Company ~~issued~~granted 7,500,000 shares of common stock to Mr. ~~Russell~~Ilgar ~~Krause~~Isayev as compensation for services rendered during the fiscal year ending September 30, ~~2025~~2026. ~~The~~As ~~shares~~of ~~were~~this ~~valued~~filing atdate, athese ~~fair~~shares ~~value~~were ofrecorded ~~$41,250~~as onstock ~~the~~payable ~~grant~~within ~~date, based on~~ the ~~closing~~shareholders’ ~~market~~equity, ~~price~~pending ~~of $0~~issuance.~~0055 per share.~~

~~On November 20, 2024, the Company entered into a convertible loan agreement with an investor.~~ Pursuant to the terms of ~~the~~a consulting agreement, the Company ~~issued~~granted 10250,000~~,000~~ shares of common stock to ~~the noteholder~~Mr. ~~The~~Stephen ~~shares~~Barnett ~~were~~as ~~valued~~compensation atfor aservices ~~fair~~rendered during ~~value~~the offiscal ~~$90,000,~~year ~~based~~ending onSeptember ~~the~~30, ~~market~~2026. ~~price~~As of ~~$0.0090~~this ~~per share~~filing ondate, these shares were recorded as stock payable within the ~~date~~shareholders’ equity, ofpending issuance.

OnAs ~~November 21, 2024,~~consideration ~~the~~for ~~Company~~their ~~entered~~fundraising ~~into~~activities aand ~~convertible~~contributions ~~loan agreement with an investor. Pursuant~~ to the ~~terms of the agreement~~Company, the Company ~~issued~~granted 108,000,000 shares of common stock to ~~the~~Parallel ~~noteholder.~~40 LLC ~~The~~as ~~shares~~compensation ~~were~~for ~~valued~~services atrendered aduring ~~fair~~the ~~value~~fiscal ofyear ~~$90~~ending September 30,~~000,~~ ~~based~~2026. onAs ~~the~~of ~~market~~this ~~price~~filing ofdate, ~~$0.0090~~these ~~per~~shares were ~~share~~recorded onas stock payable within the ~~date~~shareholders’ ofequity, pending issuance.

On ~~December~~October 222, ~~2024~~2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company ~~issued~~agreed 1to issue 5,~~105~~000,~~884~~ 000 shares of common stock to the noteholder. The shares were valued at a fair value of $~~111~~500, based on the market price of $0.0001 per share on the date of the loan agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On October 22, 2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company agreed to issue 5,000,000 shares of common stock to the noteholder. The shares were valued at a fair value of $500, based on the market price of $0.0001 per share on the date of the loan agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On November 19, 2025, the Company entered into a debt conversion agreement with a related party, the Chief Operating Officer, to settle outstanding obligations totaling $645,000. Pursuant to the terms of the agreement, the Company agreed to issue 43,000,000 shares of common stock to the related party in full satisfaction of the debt. The shares were valued at a fair value of $460,100, based on the market price of $0.0107 per share on the date of the agreement. The carrying amount of the debt exceeded the fair value of the shares to be issued by $184,900; however, due to the related-party nature of the transaction, no gain or loss was recognized in the Company’s statement of operations. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance. Upon issuance of the shares, the difference between the carrying amount of the debt and the fair value of the shares will be recorded as an adjustment to additional paid-in capital.

On December 2, 2025, the Company entered into a loan extension and amendment agreement with an investor. Pursuant to the terms of the agreement, the Company agreed to issue 466,212 shares of common stock to the noteholder. The shares were valued at a fair value of $6,667, based on the market price of $0.0143 per share on the date of the loan agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 2, 2025, the Company entered into a loan extension and amendment agreement with an investor. Pursuant to the terms of the agreement, the Company agreed to issue 608,233 shares of common stock to the noteholder. The shares were valued at a fair value of $8,698, based on the market price of $0.0143 per share on the date of the loan agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 3, 2025, the Company entered into a debt conversion agreement with a consultant to settle outstanding obligations totaling $130,000. Pursuant to the terms of the agreement, the Company agreed to issue 12,380,952 shares of common stock to the consultant in full satisfaction of the debt. The shares were valued at a fair value of $172,095, based on the market price of $0.0139 per share on the date of the agreement. As a result, the Company will recognize a loss on debt settlement of $42,095, representing the excess of the fair value of the shares to be issued over the carrying amount of the debt. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 3, 2025, the Company entered into a debt conversion agreement with a consultant to settle outstanding obligations totaling $4,200. Pursuant to the terms of the agreement, the Company agreed to issue 420,000 shares of common stock to the consultant in full satisfaction of the debt. The shares were valued at a fair value of $5,838, based on the market price of $0.0139 per share on the date of the agreement. As a result, the Company will recognize a loss on debt settlement of $1,638, representing the excess of the fair value of the shares to be issued over the carrying amount of the debt. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 9, 2025, the Company entered into a debt conversion agreement with a related party, the Chief Operating Officer/Australia, to settle outstanding obligations totaling $110,000. Pursuant to the terms of the agreement, the Company agreed to issue 7,333,333 shares of common stock to the related party in full satisfaction of the debt. The shares were valued at a fair value of $43,047, based on the market price of $0.0059 per share on the date of the agreement. The carrying amount of the debt exceeded the fair value of the shares to be issued by $66,953; however, due to the related-party nature of the transaction, no gain or loss was recognized in the Company’s statement of operations. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance. Upon issuance of the shares, the difference between the carrying amount of the debt and the fair value of the shares will be recorded as an adjustment to additional paid-in capital.

On December 29, 2025, the Company entered into a share purchase agreement with a shareholder to issue 10,000,000 shares of common stock for cash at a purchase price of $0.0067 per share. The shares were valued at a fair value of $155,000 based on the market price of $0.0155 per share on the date of the purchase agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 29, 2025, the Company entered into a share purchase agreement with a shareholder to issue 1,000,000 shares of common stock for cash at a purchase price of $0.0067 per share. The shares were valued at a fair value of $15,500 based on the market price of $0.0155 per share on the date of the agreement. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

Pursuant to a Share Purchase Agreement entered into between the Company’s subsidiary, The Quartz & Silicon Materials Company Pty Ltd., and certain investors, the Company agreed to issue 80,000 shares of its common stock to such investors. As of this filing date, these shares were recorded as stock payable within the shareholders’ equity, pending issuance.

On December 2, 2024, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company issued 847,660 shares of common stock to the noteholder. The shares were valued at a fair value of $85, based on the market price of $0.0001 per share on the date of issuance.

On January 21, 2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company issued 10,000,000 shares of common stock to the noteholder. The shares were valued at a fair value of $200,000, based on the market price of $0.0015 per share on the date of issuance.

On February 26, 2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company issued 1,666,500 shares of common stock to the noteholder. The shares were valued at a fair value of $2,500 based on the market price of $0.0015 per share on the date of issuance.

On February 26, 2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company issued 344,128 shares of common stock to the noteholder. The shares were valued at a fair value of $516 based on the market price of $0.0015 per share on the date of issuance.

Pursuant to the terms of a consulting agreement, the Company issued 10,000,000 shares of common stock to Mr. David Halstead as compensation for services rendered during the fiscal year ending September 30, 2025. The shares were valued at a fair value of $30,000 on the grant date, based on the closing market price of $0.0030 per share.

Pursuant to the terms of a consulting agreement, the Company issued 12,000,000 shares of common stock to Mr. Yan Zhou as compensation for services rendered during the fiscal year ending September 30, 2025. The shares were valued at a fair value of $36,000 on the grant date, based on the closing market price of $0.0030 per share.

On April 10, 2025, the Company entered into a convertible loan agreement with an investor. Pursuant to the terms of the agreement, the Company issued 2,500,000 shares of common stock to the noteholder. The shares were valued at a fair value of $7,500, based on the market price of $0.0030 per share on the date of issuance.

On June 11, 2025, the Company entered into a debt conversion agreement with a consultant to settle outstanding obligations totaling $110,000. Pursuant to the terms of the agreement, the Company issued 22,000,000 shares of common stock to the consultant in full satisfaction of the debt. The shares were valued at a fair value of $4,400, based on the market price of $0.0002 per share on the date of issuance. The Company recognized a gain on debt settlement of $105,600, representing the excess of the carrying amount of the debt over the fair value of the shares issued.

On June 13, 2025, the Company completed a share purchase with a shareholder for 1,000,000 shares of common stock. The shares were issued for cash at a purchase price of $0.01 per share. The shares were valued at a fair value of $200, based on the market price of $0.0002 per share on the date of issuance.

On June 26, 2025, the Company entered into a debt conversion agreement with a consultant to settle outstanding obligations totaling $1,000. Pursuant to the terms of the agreement, the Company issued 200,000 shares of common stock to the consultant in full satisfaction of the debt. The shares were valued at a fair value of $40, based on the market price of $0.0002 per share on the date of issuance. The Company recognized a gain on the debt settlement of $960, representing the excess of the carrying amount of the debt over the fair value of the shares issued.

During the quarter ended June 30, 2025, the Company issued 46,700,000 shares of the Company’s common stock to members of the Board of Directors, employees, and consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, aggregated $77,940.

Total stock-based compensation expense was $387,650 for the nine-months ended June 30, 2025.

Non-Controlling Interest

Wafer Manufacturing Corporation (“WMC”) is a consolidated joint venture in which the Company holds a 75% ownership interest. The remaining 25% is owned by a non-controlling interest. As a majority owner, the Company consolidates WMC’s financial results in its consolidated financial statements.

For the ~~three~~ ~~months~~quarter ended December ~~June 30~~31, 2025, the Company recorded a gain of $29753 attributable to the non-controlling interest in WMC, representing the portion of WMC’s net loss allocable to the minority ownership.

~~For~~During the ~~nine months~~quarter ended ~~June~~December 3031, 2025, the Company ~~recorded~~sold additional shares of its subsidiary, The Quartz & Silicon Materials Company Pty Ltd. (“QSM/AU”), resulting in third-party investors holding a ~~gain~~total of 22.73% of the subsidiary’s outstanding equity and an increase in non-controlling interest. In connection with the transaction, $~~428~~1,519 was recorded as non-controlling interest within stockholders’ equity, representing the ownership interest attributable to the minority shareholders. Additionally, the Company recognized a $3,054 increase to additional paid-in capital related to the gain on the sale of the non-controlling interest, inrepresenting ~~WMC~~the excess of the consideration received over the carrying value of the interest sold.

NOTE 8 – LEASES

The Company maintains its principal office at 11201 North Tatum Blvd., Suite 300 Phoenix, AZ 85028. The Company moved in November 2023 and its office is in a shared office space provider, at a cost of $278 per month and currently the lease is month-to-month.

Right of use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right of use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The operating lease right of use asset also excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

As part of the acquisition of Ausquartz Group Holdings Pty Ltd on July 28, 2024, the Company assumed an existing lease for office and warehouse space located in Melbourne, Australia. The lease commenced on November 1, 2023, with a four-year term and includes annual fixed rent increases of 4%.

The Company evaluated the lease and determined that it should be classified as an operating lease, as none of the criteria for a finance lease were met. As of the lease commencement date, the Company recorded a right-of-use (ROU) asset of $158,933 and a corresponding lease liability of $161,791, representing the present value of future minimum lease payments. The present value was calculated using an incremental borrowing rate of 10%, which reflects the Company’s estimated secured borrowing rate in a comparable economic environment and lease term.

As of ~~June 30~~December 31, 2025, the balance sheet includes a ROU asset of $~~117~~96,~~994~~126 and lease liabilities of $~~122~~100,~~328~~577 related to this lease.

The future minimum payments on operating leases for each of the next three years and in the aggregate amount to the following:

Schedule of future minimum payments on operating leases
Schedule of future minimum payments
		In USD
2025	$	$46,968
2026	$	$68,952
2026		55,338
2027		95,307
2027		61,939
2028		7,968
Total operating lease liabilities	$	$~~164~~172,~~245~~227

Rent ~~expense~~ expense for the period ended ~~June~~December 3031, 2025 and 2024 was $5415,~~610~~645 and $117,~~453~~031, respectively, and is included in “General and Administrative” expenses on the related statements of operations.

Finance Leases

As of ~~June~~December 3031, ~~2025~~ 2025 and ~~June~~December 3031, 2024, the Company had no finance leases.

NOTE 9 – OTHER RECEIVABLE

As of September 30, 2024, the balance of Other Receivables included $89,864 related to a research and development (R&D) tax incentive received from the Australian government. This amount represents a refundable tax offset under the Australian R&D Tax Incentive program, based on eligible R&D expenditures incurred during the relevant period.

During the 2024 fiscal year, the Company entered into an arrangement with a third-party financing provider that advanced funds to the Company based on the anticipated rebate. Upon receipt of the rebate from the Australian Taxation Office in October 2024, the financing provider deducted its fees and remitted the net proceeds to the Company. During the year ended September 30, 2025, the Company collected $21,705. The remainder was written off to expenses.

Company. During the nine months ended June 30, 2025, the Company collected $21,705. The remainder was written off to expenses.

NOTE 10 – SUBSEQUENT EVENTS

~~Mr.~~Pursuant ~~Jason~~to ~~May~~the ~~was~~terms ~~issued~~of ~~500~~a consulting agreement executed on January 1, 2026, the Company granted 10,000,000 shares ~~for~~of ~~their~~common ~~annual~~stock ~~director~~to ~~compensation~~Mr. ~~The~~Paul ~~Company~~Saffron ~~issued~~as ~~the~~a sign-on ~~shares~~bonus. inAs ~~the~~of ~~fourth~~this ~~quarter~~filing ofdate, ~~the~~these ~~fiscal~~shares ~~year 2025~~have been approved but remain unissued.

~~Mr.~~Pursuant ~~David~~to ~~Halstead~~the terms ~~was~~of ~~issued~~a ~~500~~consulting agreement executed on January 1, 2026, the Company granted 3,000,000 shares ~~for~~of ~~their~~common ~~annual~~stock ~~director~~to ~~compensation~~Mr. ~~The~~Danny ~~Company~~Kennedy ~~issued~~as ~~the~~a sign-on ~~shares~~bonus. inAs ~~the~~of ~~fourth~~this ~~quarter~~filing ofdate, ~~the~~these ~~fiscal~~shares ~~year 2025~~have been approved but remain unissued.

~~Mr.~~Pursuant ~~Jeffrey~~to ~~Freedman~~the terms ~~was~~of ~~issued~~a ~~500~~consulting agreement executed on January 1, 2026, the Company granted 1,000,000 shares ~~for~~of ~~their~~common ~~annual~~stock ~~director~~to ~~compensation~~Mr. ~~The~~Victor ~~Company~~Pereira ~~issued~~as a ~~the~~sign-on ~~shares~~bonus. inAs ~~the~~of ~~fourth~~this ~~quarter~~filing ofdate, ~~the~~these ~~fiscal~~shares ~~year 2025~~have been approved but remain unissued.

~~Mr.~~Pursuant ~~Andrew~~to ~~Liang~~the terms ~~was~~of ~~issued~~a ~~500~~services agreement executed on February 1, 2026, the Company granted 2,400,000 shares ~~for~~of ~~their~~common ~~annual~~stock ~~director~~to ~~compensation~~Mr. ~~The~~Arnold ~~Company~~Sock. ~~issued~~As ~~the~~of this ~~shares~~filing indate, ~~the~~these ~~fourth~~shares ~~quarter~~have ofbeen ~~the~~approved ~~fiscal~~but ~~year 2025~~remain unissued.

~~Mr.~~Pursuant ~~Charles~~to ~~Wantrup~~the terms ~~was~~of ~~issued~~a debt conversion agreement, the Company has agreed to issue 7,500,000 shares ~~for~~of ~~their~~common ~~annual~~stock. ~~director~~As ~~compensation.~~of ~~The~~this ~~Company~~filing ~~issued~~date, the shares have inbeen ~~the~~approved ~~fourth~~but ~~quarter~~remain ~~of the fiscal year 2025~~unissued.

~~Brookside Communications~~Pursuant ~~was~~to ~~granted~~the ~~250,000~~terms of ~~shares~~a ~~per~~debt ~~annum~~conversion agreement, ~~per~~ the ~~terms~~Company ofhas ~~their~~agreed ~~consulting~~to ~~agreement.~~issue ~~Pursuant~~51,000 toshares ~~the~~of ~~terms~~common ofstock. ~~the~~As ~~agreement, the~~of ~~Company~~this ~~issued~~filing ~~250~~date,~~000~~ ~~shares in~~ the ~~fourth~~shares ~~quarter~~have been ofapproved ~~fiscal~~but ~~year~~remain ~~2025~~unissued.

Pursuant to the terms of ~~their~~a ~~consulting~~debt conversion agreement, ~~Ilgar~~the ~~Isayev~~Company ~~was~~has ~~granted~~agreed ~~and~~to ~~issued~~issue ~~250~~13,000,000 shares. ~~The~~of ~~Company~~common ~~issued~~stock. ~~the~~As ~~shares~~of inthis ~~the~~filing ~~fourth~~date, ~~quarter~~the ofshares ~~the~~have ~~fiscal~~been ~~year~~approved ~~2025~~but remain unissued.

Pursuant to ~~the~~Share ~~terms~~Purchase ofAgreements ~~their~~entered ~~consulting~~into ~~agreement~~between the Company’s subsidiary, ~~Omnicom~~The ~~OCC~~Quartz ~~was~~& ~~granted~~Silicon Materials Company Pty Ltd., and certain ~~issued~~investors, ~~250~~the Company agreed to issue 1,140,000 shares. ~~The~~of ~~Company~~its ~~issued~~common ~~the~~stock ~~shares~~to insuch ~~the~~investors. ~~fourth quarter~~As of ~~the~~this ~~fiscal~~filing ~~year~~date, these ~~2025~~shares have been approved but remain unissued.

~~Pursuant to~~Thompson ~~the~~Family ~~terms of their consulting agreement, Rocha and Associates~~ Trust was ~~granted~~awarded ~~and issued 1~~2,000,000 shares as a performance bonus. ~~The~~As ~~Company~~of ~~issued~~this ~~the~~filing ~~shares in~~date, the ~~fourth~~shares ~~quarter~~have ofbeen ~~the~~approved ~~fiscal~~but ~~year~~remain ~~2025~~unissued.

OnMatthew ~~July~~Brown was awarded 1, ~~2025~~000,000 ~~Mr.~~shares ~~Russell~~as ~~Krause entered into~~ a ~~debt-to-equity~~performance ~~agreement with the Company~~bonus. ~~Pursuant~~As ~~to the terms~~ of ~~the~~this ~~agreement~~filing date, the ~~Company issued 8,000,000~~ shares inhave ~~the~~been ~~fourth~~approved ~~quarter~~but ofremain ~~the fiscal year 2025~~unissued.

OnMark ~~August~~Anderson was ~~11,~~awarded ~~2025~~1,000,000 ~~the~~shares ~~Company~~as ~~entered into~~ a ~~convertible~~performance ~~loan agreement~~bonus. ~~Pursuant~~As ~~to the terms~~ of ~~the~~this ~~agreement~~filing date, the ~~Company issued 5,000,000~~ shares tohave ~~the~~been ~~noteholder~~approved inbut ~~the~~remain ~~fourth quarter of the fiscal year 2025~~unissued.

On ~~August~~January 1314, ~~2025~~2026, ~~Arran~~the ~~Boote~~Company ~~entered~~filed ~~into~~Articles aof ~~debt-~~Amendment to~~-equity~~ ~~agreement~~its Articles of Incorporation with the ~~Company.~~Colorado ~~Pursuant~~Secretary of State to increase the number ~~terms~~of authorized shares of the ~~agreement~~Company’s common stock from 800,000,000 ~~the~~shares, ~~Company~~par ~~issued~~ value $0.00001 per share, to 1,500,000 ,000 shares, inpar value $0.0001 per share. The amendment was approved by the ~~fourth~~Company’s ~~quarter~~Board of Directors and became effective upon filing with the ~~fiscal~~Colorado ~~year~~Secretary ~~2025~~of State.

~~Mr.~~On ~~Anthony~~February ~~Leigh~~25, ~~was~~2026, ~~issued 5~~50,000,000 shares ~~awarded~~of ascommon astock ~~performance~~were ~~bonus.~~returned ~~The~~from ~~Company issued~~ the ~~shares~~holder inand ~~the fourth quarter of the fiscal year 2025~~cancelled.

~~STR~~The ~~Ventures~~Company ~~was~~has ~~issued~~evaluated ~~500,000~~events ~~shares~~occurring ~~awarded~~subsequent asto aDecember ~~performance~~31, ~~bonus.~~2025 ~~The~~through ~~Company~~to ~~issued~~ the ~~shares~~date inthese ~~the~~financial ~~fourth~~statements ~~quarter~~were ofissued ~~the~~and ~~fiscal~~has ~~year~~identified no ~~2025~~additional events requiring disclosure.

~~Mr. Ilgar Isayev was issued 2,000,000 shares awarded as a performance bonus. The Company issued the shares in the fourth quarter of the fiscal year 2025.~~17

On September 30, 2025, Mr. Russell Krause entered into a debt-to-equity agreement with the Company. Pursuant to the terms of the agreement, the Company issued 20,000,000 shares in the fourth quarter of the fiscal year 2025.

On September 30, 2025, Mr. Jason May entered into a debt-to-equity agreement with the Company. Pursuant to the terms of the agreement, the Company issued 16,822,000 shares in the fourth quarter of the fiscal year 2025.

On September 30, 2025, a noteholder entered into a debt-to-equity agreement with the Company. Pursuant to the terms of the agreement, the Company issued 519,444 shares in the fourth quarter of the fiscal year 2025.

Pursuant to the terms of their consulting agreement, Mr. Stuart Allen was granted 500,000 shares. As of this filing date, the shares have been approved but remain unissued.

The Company has evaluated events occurring subsequent to June 30, 2025 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

FORWARD LOOKING STATEMENTS

The information contained in this Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including among other things, statements regarding our capital needs, business strategy and expectations. Any statement which does not contain a historical fact may be deemed to be a forward-looking statement. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. In evaluating forward looking statements, you should consider various factors outlined in our Form 10-K report for the year ended September 30, ~~2024~~2025, filed with the U.S. Securities Exchange Commission (“SEC”) and, from time to time, in other reports we file with the SEC. These factors may cause our actual results to differ materially from any forward-looking statement. We disclaim any obligation to publicly update these statements or disclose any difference between our actual results and those reflected in these statements.

Overview

~~GSTX~~The isCompany ~~focused~~acquired onSolar ~~manufacturing~~Quartz ~~silicon~~Technologies ~~wafers~~Limited, ~~for~~a ~~supply~~New ~~into~~Zealand corporation with substantial mineral resource and technical engineering assets, in July 2017. Since that time the ~~solar~~Company ~~manufacturing~~has been engaged in developing several projects in the renewable energy sector, clean water and advanced materials. ~~Silicon~~At ~~wafers~~present ~~are~~the focus of the ~~core~~Company ~~material~~is ~~used~~on Silicon Wafer manufacturing for ~~making~~ the solar ~~cells~~photovoltaic manufacturing sector. ~~The~~However, ~~solar~~substantial ~~panel~~efforts ~~supply~~are ~~chain~~underway to secure funding, and we believe that funding for the Company is imminent in the near future, although no assurance can be ~~depicted~~made as ~~follows:~~to the amount of funds, if any, or the terms thereof.

~~Quartz -> silicon~~Current ->Business ~~polysilicon~~and ~~-> silicon ingots -> silicon wafers -> solar cells -> solar modules (panels)~~Operation

The ~~GSTX strategy~~company ishas toa focus ~~take~~and ~~advantage~~strategy ofto ~~the~~supply ~~geopolitical,~~silicon ~~environmental~~wafers ~~and~~for ~~supply chain challenges~~ the ~~world~~photovoltaic ~~faces~~manufacturing ~~at present~~sector. ~~GSTX~~This isleverages ~~focused~~the onexisting ~~reshoring~~company ~~solar manufacturing from China for domestic manufacturing,~~ operations and ~~sales~~planned ~~into~~production ~~domestic markets.~~of ~~GSTX is also developing projects in the~~ upstream supply chain tocomponents ~~maintain~~(quartz ~~its~~sand, ~~own supply chain security for its silicon wafer manufacturing. This includes quartz~~crucibles, silicon and polysilicon). The ~~year end September 30, 2024, was marked by significant progress in project development activities. The~~ company ~~has~~is ~~restructured its operations. Previous business of thin films and water harvesting have~~exploring ~~been~~partnerships ~~paused.~~with ~~The company has~~ established aincumbent ~~wholly~~manufacturers ~~owned~~to ~~subsidiary,~~reshore ~~The~~silicon ~~Quartz~~wafer &and ~~Silicon~~solar ~~Materials~~photovoltaic ~~Company~~cell ~~Limited~~production to ~~develop~~the ~~its~~USA, Australia ~~solar~~and ~~manufacturing related projects~~Europe. ~~Early planning for several projects is underway, including:~~

·In ~~Acquisition~~2024, the Company completed the acquisition of ~~quartz~~Ausquartz ~~resources~~Group inHoldings ~~Australia.~~Pty ~~Development~~Ltd, ofa ~~several~~company ~~prospective~~associated ~~resources~~with inour ~~Brail~~CEO, ~~USA~~Jason May. Ausquartz specializes in the processing of high-purity quartz, ~~Canada~~a key upstream material for solar manufacturing. This acquisition was undertaken to secure strategic control over a critical raw material input—high-purity quartz—and ~~Europe~~to support the Company's vertical integration strategy. The transaction aligns with our broader business plan to develop a secure, domestic supply chain for silicon wafer manufacturing.

·To Afurther ~~completed~~this ~~acquisition~~strategy, in of2024, ~~Ausquartz~~we ~~Group~~established ~~Holding~~a ~~Pty~~wholly ~~Ltd~~owned subsidiary, aThe ~~company~~Quartz ~~associated~~& ~~with~~Silicon ~~CEO~~Materials ~~Jason~~Company ~~May~~Limited (“QSM”), ~~specializing~~to inlead ~~high~~the development ~~purity~~of ~~quartz~~integrated ~~processing~~solar manufacturing projects. These include early-stage planning and permitting for:

~~· A 10GW wafer facility in the USA,~~18

· A 10GW silicon wafer manufacturing facility in ~~Australia,~~the U.S.

· A ~~60,000~~10GW ~~metric~~wafer ~~ton~~facility ~~chemical grade silicon smelter~~ in ~~New Zealand~~Australia.

· A 60,000 metric ton chemical-grade silicon smelter and a 30,000 metric ton solar -grade polysilicon plant, both in New Zealand.

Acquisition and development of quartz resources in Australia, Brazil, the U.S., Canada, and Europe.

Funding and Business Outlook

The Company is currently engaged in advanced discussions with multiple large incumbent manufacturers regarding potential joint ventures and offtake agreements related to silicon ingot, wafer, and cell manufacturing.
We are actively pursuing a combination of equity and debt financing, as well as governmental support under the U.S. One Big Beautiful Bill Act and Australia’s Made in Australia initiatives. While these discussions are ongoing, no binding agreements have been executed as of the date of this filing.
The passage of the One Big Beautiful Bill Act in July 2025 has helped clarify the U.S. policy landscape, preserving critical incentives such as the Section 45 manufacturing production credit. This legislative clarity supports our confidence in pursuing domestic solar manufacturing projects.
QSM’s business model is based on proven technologies with minimal R&D risk; the Company does not intend to develop new technology but rather to manufacture established silicon wafer products at scale. This lowers the technical and commercialization risks typically associated with early-stage manufacturing ventures.

Status of Commercial Product Development

While the Company has not generated revenues in fiscal years 2024 or 2025, it made significant progress in engineering, planning, and permitting activities.
The Company’s commercial product is standard silicon wafers used in the solar supply chain. These wafers are not subject to additional R&D prior to production. The remaining requirements are infrastructure development, equipment procurement, and commissioning.
We anticipate initial sample production to begin following completion of financing and facility construction phases.

The Company is actively recruiting new members of the management team to assist with implementing its strategic plan. The company is re-engaging various opportunities that it was pursuing pre-pandemic.

Currently, GSTX is primarily focused upon completing development and initial sample production of commercially viable silicon wafers and solar cells. The goal for FY 2026 is to establish initial production and begin generating revenue.

Results of Operations

For the fiscal quarters ended December 31, 2025 and 2024, we generated no revenues, and thus no cost of sales or gross profits.

For the fiscal quarters ended December 31, 2025 and 2024, we incurred $759,871 and $965,764, respectively, in operating expenses.

For the fiscal quarter ended December 31, 2025, we recorded other expenses of $102,826, while in the fiscal quarter ended December 31, 2024, we incurred other expenses of $76,853; both items are represented by accrued interest on debt.

For the three-months ended December 31, 2025, we reported net loss before taxes of $687,498 while in the three-months ended December 31, 2024, we reported a net loss before taxes of $940,408.

~~The~~For ~~US Inflation Reduction Act under~~ the ~~Biden~~periods ~~era administration had strong financial support for a wide range of renewable businesses, including solar~~ended ~~manufacturing.~~December ~~With the change of administration~~31, ~~the~~2025 ~~Trump era, significantly changed the policies~~ and ~~support~~September ~~for renewables as part of the One Big Beautiful Bill Act. This was signed into law on July 4~~30, 2025., ~~The~~our UScash ~~presidential~~positions ~~election~~were ~~and the first 6 months of Trump’s presidency caused a significant amount of uncertainty in the solar manufacturing sector. This did affect the operations of GSTX~~$78,842 but thankfully with the passing of the One Big Beautiful Bill there is now positive certainty regarding solar manufacturing incentives. In particular the section 45 manufacturing production credit framework has survived amendment and ~~is a positive outcome for US solar manufacturing~~$57, ~~and~~365, ~~the GSTX business strategy~~respectively.

As of December 31, 2025, we had total current liabilities of $4,700,487 while as of September 30, 2025, we had total current liabilities of $4,817,878 an decrease of about 2%. Accrued interest payable increased from $248,881 to $271,258 all attributable to accruals on the loans and the convertible notes payable. Related party debt decreased from $1,836,248 to $1,531,763 during the period.

Liquidity and Capital Resources

WeAs ~~expect~~of toDecember ~~require~~31, ~~substantial~~2025, ~~additional~~we ~~financing~~had to$90,354 ~~fund~~in ~~the~~total ~~construction~~current assets and ~~commissioning~~$4,700,487 ofin ~~our~~total ~~planned~~current ~~manufacturing facilities~~liabilities. WeAccordingly, ~~intend~~we tohad ~~pursue~~ a ~~combination~~working capital deficit of ~~equity financing~~$4, ~~debt financing~~610, ~~government incentives, and customer offtake arrangements~~133. ~~There can be no assurance that such financing will be available on acceptable terms or at all.~~

~~Supply~~Cash ~~Chain~~used in operating ~~and~~activities ~~Development~~was ~~Activities~~$107,078 for the three-months ended December 31, 2025, as compared to $99,555 cash used in operating activities for the three-months ended December 31, 2024.

~~The~~Cash ~~Company has been~~used in ~~advanced~~investing ~~discussion~~activities ~~with~~was ~~several large incumbent manufacturers to reshore manufacturing of silicon ingots~~$13,218 ~~wafers~~for ~~and cells to~~ the US ~~and~~three-months ~~Australia.~~ended ~~QSM~~December is31, ~~structured~~2025, toas ~~take~~compared ~~advantage of the US One Big Beautiful Bill Act and the Australian “Made in Australia” programs~~ to ~~reshore~~$0 ~~critical~~cash ~~solar~~used ~~manufacturing. Producing wafers locally (Made~~ in ~~America/Made~~investing ~~in Australia) is key to being able to~~activities ~~claim~~for ~~government~~the ~~incentives~~three-months ~~(production~~ended ~~credits).~~December ~~QSM is a low technology risk enterprise~~31, ~~no new inventions, just manufacturing~~2024.

~~Outlook~~Net cash provided by financing activities was $272,900 for the three-months ended December 31, 2025, as compared to $199,416 for the three-months ended December 31, 2024.

For fiscal year 2025, the Company expects to continue project development activities, including establishing manufacturing joint ventures, detailed engineering, permitting, offtake sales and financing. We expect to continue to incur operating losses and negative operating cash flows until commercial operations commence. The timing of revenue generation is dependent on the successful completion of project financing and construction of the Company’s planned manufacturing facilities.

Results of Operations

For the fiscal quarters ended June 30, 2025 and 2024, we generated no revenues, and thus no cost of sales or gross profits.

For the fiscal quarters ended June 30, 2025 and 2024, we incurred $803,874 and $304,825, respectively, in operating expenses.

For the fiscal quarters ended June 30, 2025 we recorded other expenses of $73,837, while in the fiscal quarters ended June 30, 2024, we incurred expenses of $14,798; both items are represented by accrued interest on debt. Other income/(expense) of $5 was incurred in the fiscal quarter, June 30, 2025 and a loss of $4,792 in fiscal quarter, June 30, 2024.

For the nine-months ended June 30, 2025, we reported net loss before taxes of $2,565,809 while in the nine-months ended June 30, 2024, we reported a net loss before taxes of $1,060,293.

For the periods ended June 30, 2025 and September 30, 2024, our cash positions were $42,791 and $1,845, respectively.

As of June 30, 2025, we had total current liabilities of $4,859,561 while as of September 30, 2024, we had total current liabilities of $3,026,409 an increase of about 37%. Accrued interest payable increased from $222,679 to $260,062 all attributable to accruals on the loans and the convertible notes payable. Related party debt increased from $852,743 to $2,209,249 during the period.

Liquidity and Capital Resources

As of June 30, 2025, we had $54,057 in total current assets and $4,859,561 in total current liabilities. Accordingly, we had a working capital deficit of $4,805,504.

Cash used in operating activities was $327,489 for the nine-months ended June 30, 2025, as compared to $53,161 cash used in operating activities for the nine-months ended June 30, 2024.

Net cash provided by financing activities was $367,172 for the nine-months ended June 30, 2025, as compared to $77,399 for the nine-months ended June 30, 2024.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 1.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, ~~2024~~2025 due to the material weaknesses in internal control over financial reporting described below.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Management conducted an assessment of the effectiveness of our internal control over financial reporting as of September 30, ~~2024~~2025 based on the criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this assessment, management concluded that our internal control over financial reporting was not effective as of September 30, ~~2024~~2025 due to the existence of the material weaknesses identified below:

Inadequate segregation of duties in the financial reporting process;
Lack of sufficient personnel with appropriate accounting expertise;
Ineffective controls over the review of journal entries and account reconciliations;
Insufficient controls over the completeness and accuracy of disclosures.

These material weaknesses could result in a material misstatement of our financial statements or disclosures that may not be prevented or detected on a timely basis.

Disclosure of Fraud

In connection with the certifications required under Rules 15d-14(a) and 15d-14(b) of the Exchange Act, our Chief Executive Officer and Chief Financial Officer have disclosed to our auditors, the audit committee of our board of directors, and in this report, any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. As of the date of this filing, management is not aware of any such instances of fraud that occurred during the fiscal year ended September 30, ~~2024~~2025.

Remediation Efforts

We are in the process of designing and implementing measures to remediate the material weaknesses described above. These measures include, but are not limited to:

Hiring additional accounting personnel with relevant expertise;
Implementing enhanced review procedures and formalized documentation controls;
Establishing more robust segregation of duties within the finance and accounting functions;
Providing additional training and resources to employees involved in financial reporting.

Management is committed to remediating the identified material weaknesses as quickly and effectively as possible. We will continue to assess the effectiveness of our internal control over financial reporting and will disclose any changes in future filings.

Changes in Internal Control over Financial Reporting

Other than the remediation efforts described above, there were no changes in our internal control over financial reporting that occurred during the ~~second~~first quarter of our fiscal year ended September 30, ~~2025~~2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our annual report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Please see Note 5 to our Financial Statements.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibits

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

32.2	Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GRAPHENE & SOLAR TECHNOLOGIES LIMITED
Date: November 12, 2025	By:	/s/ Jason May
Date: April 10, 2026	By:	/s/ Jason May
		Chief Executive Officer and Director

Filing Compare · Graphene & Solar Technologies Ltd